{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:37:20Z","timestamp":1789983440257,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.amjcard.2015.07.020","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T22:55:06Z","timestamp":1437087306000},"page":"1057-1062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Relation of Combined Non\u2013High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in\u00a0Adults With Type 1 Diabetes Mellitus"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-2947","authenticated-orcid":false,"given":"Petter","family":"Bjornstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Rewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Maahs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Snell-Bergeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.07.020_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2011.05.009","article-title":"Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math","volume":"58","author":"Ramjee","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study","volume":"358","author":"Walldius","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.07.020_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.07.020_bib4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","article-title":"Relationship of apolipoproteins A-1 and B, and lipoprotein (a) to cardiovascular outcomes: the AIM-High Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL\/High Triglyceride and Impact on Global Health Outcomes)","volume":"62","author":"Albers","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2008.03.054","article-title":"Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study","volume":"52","author":"Juonala","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MOL.0b013e32833ee80c","article-title":"Non-HDL C equals apolipoprotein B: except when it does not!","volume":"21","author":"Sniderman","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jacl.2014.08.008","article-title":"Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study","volume":"8","author":"Bjornstad","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db10-0328","article-title":"Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study","volume":"60","author":"Schauer","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.amjcard.2015.07.020_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-149-11-200812020-00009","article-title":"When should a new test become the current reference standard?","volume":"149","author":"Glasziou","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2015.07.020_bib10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"Brunzell","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2015.07.020_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models","volume":"176","author":"Pencina","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib13","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","article-title":"Statistical methods for assessment of added usefulness of new biomarkers","volume":"48","author":"Pencina","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.amjcard.2015.07.020_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7326\/M13-1522","article-title":"Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide","volume":"160","author":"Leening","year":"2014","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2015.07.020_bib15","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2015.07.020_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.07.020_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0895-4356(93)90033-W","article-title":"Tracking of serum apolipoproteins A-I and B in children and young adults: the Bogalusa Heart Study","volume":"46","author":"Bao","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.clinbiochem.2009.05.013","article-title":"Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy","volume":"42","author":"Mazanderani","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.amjcard.2015.07.020_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9149(03)00262-5","article-title":"Concordance\/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk","volume":"91","author":"Sniderman","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2015.07.020_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.07.020_bib22","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.07.020_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/CIRCULATIONAHA.113.007207","article-title":"Are we moving towards concordance on the principle that lipid discordance matters?","volume":"129","author":"Martin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.07.020_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel","volume":"259","author":"Barter","year":"2006","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.amjcard.2015.07.020_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4065\/mcp.2011.0128","article-title":"Opening a new lipid \u201capo-thecary\u201d: incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk","volume":"86","author":"Jacobson","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2015.07.020_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-12-39","article-title":"Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM","volume":"12","author":"Hermans","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2840-10-20","article-title":"Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant ratio and unbiased equivalence","volume":"10","author":"Hermans","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2015.07.020_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2283021006","article-title":"Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality","volume":"228","author":"Shaw","year":"2003","journal-title":"Radiology"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915016306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915016306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T05:56:21Z","timestamp":1617170181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915016306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0002914915016306"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.07.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of Combined Non\u2013High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in\u00a0Adults With Type 1 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}